Literature DB >> 28360765

Effectiveness of Greater Occipital Nerve Blocks in Migraine Prophylaxis.

Nurten Inan1, Levent E Inan2, Özlem Coşkun3, Tuğba Tunç4, Mustafa Ilhan5.   

Abstract

INTRODUCTION: Peripheral nerve blocks have been used in primary headache treatment since a long time. In this study, we aimed to examine the efficiency of greater occipital nerve (GON) block in migraine prophylaxis.
METHODS: Data from migraine without aura patients who had GON block were collected and divided into two groups: Group PGON (n=25), which included patients who were under medical prophylaxis and had GON block, and Group GON (n=53), which included patients who had only GON blocks. Migraine was diagnosed using International Headache Society (IHS) classification. Data of 78 patients were analyzed. Headache attack frequency, headache duration, and severity were compared between and within groups in a 3-month follow-up period.
RESULTS: The decrease in headache parameters after GON block in both groups was significantly similar. Headache attack frequency decreased from 15.73±7.21 (pretreatment) to 4.52±3.61 (3rd month) in Group GON and from 13.76±8.07 to 3.28±2.15 in Group PGON (p<0.05). Headache duration decreased from 18.51±9.43 to 8.02±5.58 at 3rd month in Group GON and from 15.20±9.16 to 7.20±4.16 in Group PGON (p<0.05). Headache severity decreased from 8.26±1.32 to 5.16±2.64 in Group GON and from 8.08±0.90 to 5.96±1.20 in Group PGON (p<0.05). There was no statistically significant difference between the groups in 3rd month after treatment (p>0.05).
CONCLUSION: This study showed significant decreases in headache parameters in both groups. As GON blocks were performed in patients unresponsive to medical prophylaxis, a decrease in the headache parameters in Group PGON similar to that in Group GON can be attributed to GON blocks. Consequently, these results show that repeated GON blocks with local anesthetic can be an effective alternative treatment in migraine patients who are unresponsive to medical prophylaxis or who do not prefer to use medical prophylaxis.

Entities:  

Keywords:  Headache; greater occipital nerve block; migraine; prophylaxis

Year:  2016        PMID: 28360765      PMCID: PMC5353237          DOI: 10.5152/npa.2015.10003

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  19 in total

1.  Occipital nerve block rapidly eliminates allodynia far from the site of headache: a case report.

Authors:  W B Young; V Mateos; A Ashkenazi
Journal:  Cephalalgia       Date:  2004-10       Impact factor: 6.292

2.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

3.  Therapeutic blockade of greater occipital and supraorbital nerves in migraine patients.

Authors:  C A Caputi; V Firetto
Journal:  Headache       Date:  1997-03       Impact factor: 5.887

4.  Efficacy of local lidocaine application on anxiety and depression and its curative effect on patients with chronic tension-type headache.

Authors:  Ömer Karadaş; Levent E Inan; Ümit H Ulaş; Zeki Odabaşi
Journal:  Eur Neurol       Date:  2013-07-02       Impact factor: 1.710

Review 5.  Occipital nerve block in the management of headache and cervical pain.

Authors:  M J Gawel; P J Rothbart
Journal:  Cephalalgia       Date:  1992-02       Impact factor: 6.292

6.  Patterns of use of peripheral nerve blocks and trigger point injections among headache practitioners in the USA: Results of the American Headache Society Interventional Procedure Survey (AHS-IPS).

Authors:  Andrew Blumenfeld; Avi Ashkenazi; Brian Grosberg; Uri Napchan; Samer Narouze; Bob Nett; Traci DePalma; Barbara Rosenthal; Stewart Tepper; Richard B Lipton
Journal:  Headache       Date:  2010-06       Impact factor: 5.887

7.  Greater occipital nerve block in chronic migraine.

Authors:  Maria Gabriella Saracco; W Valfrè; M Cavallini; M Aguggia
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

8.  C2/C3 nerve blocks and greater occipital nerve block in cervicogenic headache treatment.

Authors:  N Inan; A Ceyhan; L Inan; O Kavaklioglu; A Alptekin; N Unal
Journal:  Funct Neurol       Date:  2001 Jul-Sep

9.  Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study.

Authors:  A Ashkenazi; R Matro; J W Shaw; M A Abbas; S D Silberstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-08-06       Impact factor: 10.154

10.  Occipital nerve blocks: effect of symptomatic medication: overuse and headache type on failure rate.

Authors:  Joshua A Tobin; Stephen S Flitman
Journal:  Headache       Date:  2009 Nov-Dec       Impact factor: 5.887

View more
  4 in total

1.  Effectiveness of peripheral nerve blockage on the symptoms of both diseases in patients with fibromyalgia and chronic migraine coexistence.

Authors:  Gokhan Evcili; Ahmet Yabalak
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-08       Impact factor: 1.712

2.  Effectiveness of treatment of occipital neuralgia using the nerve block technique: a prospective analysis of 44 patients.

Authors:  Raimondas Juškys; Gytis Šustickas
Journal:  Acta Med Litu       Date:  2018

3.  The Public's Perception of Interventions for Migraine Headache Disorders: A Crowdsourcing Population-Based Study.

Authors:  Orr Shauly; Daniel J Gould; Ketan M Patel
Journal:  Aesthet Surg J Open Forum       Date:  2019-04-02

4.  Comparison of greater occipital nerve and greater occipital nerve + supraorbital nerve block effect in chronic medication overuse headache

Authors:  Nermin Tepe; Oktay Faysal Tertemiz
Journal:  Turk J Med Sci       Date:  2021-06-28       Impact factor: 0.973

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.